were used with success in FHV-1 infection, in cells of feline lung [17], kidney [20], embryo [18] or cornea [19]. However, attempts to obtain these results in vivo, with conventional doses of cytokines, like rFeIFN-omega, have only yielded modest improvements of the clinical signs and reductions in concurrent viral excretion in naturally infected FHV-1 cats